News and Events
-
Vaxosome launched to develop next-generation mRNA vaccines
A new biotechnology company, Vaxosome, has been launched to develop next-generation vaccines aimed at tackling some of the world’s most challenging infectious diseases.News Type: Research NewsDate -
Centenary partners in transformative national liver health program
The Snow Medical Research Foundation has today announced major long-term funding of $15.5 million for a new national research program targeting fatty liver disease, a condition that affects up to one in three Australians. The Centenary Institute will play a key role in the collaborative effort.News Type: Research NewsDate -
Centenary exhibition brings medical research to life in hospital spaces
The Centenary Institute’s 'When Art Meets Science' exhibition took centre stage at the recent launch of the annual Sydney Local Health District (SLHD) March Arts program.News Type: CommunityDate -
‘Mini hearts’ show COVID-19 virus directly infects heart tissue
Researchers from the Centenary Institute and the University of Technology Sydney (UTS) have developed a human heart cell model demonstrating that the virus that causes COVID‑19 (SARS-CoV-2) can directly infect heart tissue, providing new insight into why some people experience serious heart complications during and after infection.News Type: Media releaseDate